$ORLY
O REILLY AUTOMOTIVE INC

2020 Q1 Form 10-Q Financial Statement

#000089817320000027 Filed on May 08, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $2.476B $2.411B
YoY Change 2.73% 5.6%
Cost Of Revenue $1.181B $1.131B
YoY Change 4.35% 4.61%
Gross Profit $1.296B $1.279B
YoY Change 1.3% 6.5%
Gross Profit Margin 52.33% 53.07%
Selling, General & Admin $872.3M $834.5M
YoY Change 4.53% 7.21%
% of Gross Profit 67.32% 65.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $73.96M $63.96M
YoY Change 15.63% -8.52%
% of Gross Profit 5.71% 5.0%
Operating Expenses $872.3M $834.5M
YoY Change 4.53% 7.21%
Operating Profit $423.6M $444.8M
YoY Change -4.77% 5.19%
Interest Expense -$43.90M -$33.60M
YoY Change 30.65% 21.74%
% of Operating Profit -10.36% -7.55%
Other Income/Expense, Net -$43.90M -$30.63M
YoY Change 43.31% 11.64%
Pretax Income $379.7M $414.2M
YoY Change -8.33% 4.74%
Income Tax $79.22M $93.00M
% Of Pretax Income 20.87% 22.46%
Net Earnings $300.4M $321.2M
YoY Change -6.45% 5.33%
Net Earnings / Revenue 12.13% 13.32%
Basic Earnings Per Share $4.00 $4.09
Diluted Earnings Per Share $3.97 $4.05
COMMON SHARES
Basic Shares Outstanding 75.02M 78.48M
Diluted Shares Outstanding 75.66M 79.30M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $287.0M $57.00M
YoY Change 403.51% 46.15%
Cash & Equivalents $287.1M $56.72M
Short-Term Investments
Other Short-Term Assets $53.40M $46.90M
YoY Change 13.86% -10.71%
Inventory $3.557B $3.229B
Prepaid Expenses
Receivables $221.2M $250.7M
Other Receivables $84.00M $66.00M
Total Short-Term Assets $4.202B $3.650B
YoY Change 15.13% 5.9%
LONG-TERM ASSETS
Property, Plant & Equipment $4.009B $3.677B
YoY Change 9.03% 8.47%
Goodwill $910.1M $808.7M
YoY Change 12.54% 2.49%
Intangibles
YoY Change
Long-Term Investments $28.00M $3.000M
YoY Change 833.33%
Other Assets $52.98M $40.13M
YoY Change 32.04% -3.03%
Total Long-Term Assets $6.907B $6.412B
YoY Change 7.72% 51.93%
TOTAL ASSETS
Total Short-Term Assets $4.202B $3.650B
Total Long-Term Assets $6.907B $6.412B
Total Assets $11.11B $10.06B
YoY Change 10.41% 31.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.758B $3.439B
YoY Change 9.29% 6.7%
Accrued Expenses $493.0M $456.0M
YoY Change 8.11% 210.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.625B $4.326B
YoY Change 6.9% 15.42%
LONG-TERM LIABILITIES
Long-Term Debt $4.471B $3.461B
YoY Change 29.19% 8.39%
Other Long-Term Liabilities $168.6M $163.2M
YoY Change 3.36% -22.97%
Total Long-Term Liabilities $4.640B $3.624B
YoY Change 28.03% 6.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.625B $4.326B
Total Long-Term Liabilities $4.640B $3.624B
Total Liabilities $9.265B $7.950B
YoY Change 16.53% 11.15%
SHAREHOLDERS EQUITY
Retained Earnings -$1.137B -$896.5M
YoY Change 26.88% 8.74%
Common Stock $1.272B $1.269B
YoY Change 0.25% 1.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $108.8M $372.4M
YoY Change
Total Liabilities & Shareholders Equity $11.11B $10.06B
YoY Change 10.41% 31.24%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $300.4M $321.2M
YoY Change -6.45% 5.33%
Depreciation, Depletion And Amortization $73.96M $63.96M
YoY Change 15.63% -8.52%
Cash From Operating Activities $459.1M $440.6M
YoY Change 4.19% 1.93%
INVESTING ACTIVITIES
Capital Expenditures $133.3M $152.9M
YoY Change -12.84% 33.15%
Acquisitions
YoY Change
Other Investing Activities $0.00 $295.0K
YoY Change -100.0% -21.33%
Cash From Investing Activities -$226.6M -$151.4M
YoY Change 49.7% 32.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $574.1M $321.9M
YoY Change 78.36% -41.42%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.30M -263.8M
YoY Change -105.8% -18.98%
NET CHANGE
Cash From Operating Activities 459.1M 440.6M
Cash From Investing Activities -226.6M -151.4M
Cash From Financing Activities 15.30M -263.8M
Net Change In Cash 246.7M 25.40M
YoY Change 871.03% -424.71%
FREE CASH FLOW
Cash From Operating Activities $459.1M $440.6M
Capital Expenditures $133.3M $152.9M
Free Cash Flow $325.8M $287.7M
YoY Change 13.24% -9.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000898173
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
O Reilly Automotive Inc
CY2019Q4 orly Non Financial Assets And Liabilities Fair Value Nonrecurring
NonFinancialAssetsAndLiabilitiesFairValueNonrecurring
0
CY2020Q1 orly Non Financial Assets And Liabilities Fair Value Nonrecurring
NonFinancialAssetsAndLiabilitiesFairValueNonrecurring
0
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74199261
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75618659
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MO
CY2020Q1 dei Entity File Number
EntityFileNumber
000-21318
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-4358837
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
233 South Patterson Avenue
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Springfield
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MO
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
65802
CY2020Q1 dei City Area Code
CityAreaCode
417
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
862-6708
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2020Q1 dei Trading Symbol
TradingSymbol
ORLY
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
221167000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
214915000
CY2020Q1 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
83446000
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
74225644
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
287067000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40406000
CY2019Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
79492000
CY2020Q1 us-gaap Inventory Net
InventoryNet
3556723000
CY2019Q4 us-gaap Inventory Net
InventoryNet
3454092000
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
53397000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
44757000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
4201800000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
3833662000
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6314339000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6191427000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2305695000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2243224000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4008644000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3948203000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1935295000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1928369000
CY2020Q1 us-gaap Goodwill
Goodwill
910141000
CY2019Q4 us-gaap Goodwill
Goodwill
936814000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
52982000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
70112000
CY2020Q1 us-gaap Assets
Assets
11108862000
CY2019Q4 us-gaap Assets
Assets
10717160000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3758199000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3604722000
CY2020Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
83262000
CY2019Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
79079000
CY2020Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
103804000
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
100816000
CY2020Q1 orly Accrued Benefits And Withholdings
AccruedBenefitsAndWithholdings
72561000
CY2019Q4 orly Accrued Benefits And Withholdings
AccruedBenefitsAndWithholdings
98539000
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
12884000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25402000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40406000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31315000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
287067000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
316932000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
316061000
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
277290000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
270210000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4624932000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4469427000
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4471248000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3890527000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1661991000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1655297000
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
73212000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
133280000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
168635000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
171289000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
245000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
245000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74199261
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75618659
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
742000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
756000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1271250000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1280760000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1137392000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-889066000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25756000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4890000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
108844000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
397340000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11108862000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10717160000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2476487000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2410608000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1180581000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1131318000
CY2020Q1 us-gaap Gross Profit
GrossProfit
1295906000
CY2019Q1 us-gaap Gross Profit
GrossProfit
1279290000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
872345000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
834504000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
423561000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
444786000
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
39386000
CY2019Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
34291000
CY2020Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
675000
CY2019Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
554000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
414152000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2322000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5190000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3103000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-43901000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30634000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
379660000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79222000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
93000000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
300438000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
321152000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.00
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.09
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75022000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78484000
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.97
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.05
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75663000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79297000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
300438000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
321152000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-30646000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-30646000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
269792000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
321152000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
397340000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
300438000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-30646000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
4104000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6136000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5524000
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
574052000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
108844000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
353667000
CY2018Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-1410000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
321152000
CY2019Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
3772000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11955000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5085000
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
321856000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
372365000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
300438000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
321152000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
73963000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
63964000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1035000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56717000
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
4975000
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
5335000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
46282000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
47796000
CY2020Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-family:'Times New Roman';font-size:10pt;font-weight:bold;margin:0pt;">NOTE 1 – BASIS OF PRESENTATION</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The accompanying unaudited condensed consolidated financial statements of O’Reilly Automotive, Inc. and its subsidiaries (the “Company” or “O’Reilly”) have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included.  Operating results for the three months ended March 31, 2020, are not necessarily indicative of the results that may be expected for the year ended December 31, 2020.  For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt 0pt 3pt 0pt;"><span style="font-style:italic;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt 0pt 3pt 0pt;"><i style="font-style:italic;">Principles of consolidation:</i></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  All inter-company balances and transactions have been eliminated in consolidation.</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt 0pt 3pt 0pt;"><i style="font-style:italic;">Variable Interest Entities:</i></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The Company invests in certain tax credit funds that promote renewable energy.  These investments generate a return primarily through the realization of federal tax credits and other tax benefits.  The Company accounts for its renewable energy investments using the deferral method.  Under this method, realized investment tax credits and other tax benefits are recognized as a reduction of the renewable energy investments. </p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The Company considers its investment in these tax credit funds as an investment in variable interest entities (“VIE”).  The Company analyzes any investments in VIEs to determine if it is the primary beneficiary.  The Company considers a variety of factors in identifying the entity that holds the power to direct matters that most significantly impact the VIE’s economic performance including, but not limited to, the ability to direct financing, leasing, construction and other operating decisions and activities.  As of March 31, 2020, the Company invested in two unconsolidated tax credit fund entities that were considered to be VIEs and concluded it was not the primary beneficiary of either entity, as it did not have the power to control the activities that most significantly impact the entities, and has accounted for these investments using the equity method.  The Company’s maximum exposure to losses associated with these VIEs is limited to its net investment, which was $14.3 million as of March 31, 2020, and was included in “Other assets, net” on the accompanying Condensed Consolidated Balance Sheets.  <i style="font-style:italic;"> </i><span style="background-color:#ffff00;"> </span></p>
CY2020Q1 orly Variable Interest Entity Equity Method Investment Carry Amount
VariableInterestEntityEquityMethodInvestmentCarryAmount
14300000
CY2019Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
918000
CY2020Q1 orly Deferred Income Tax Expense Benefit Including Asu Adoption Adjustment Impact
DeferredIncomeTaxExpenseBenefitIncludingASUAdoptionAdjustmentImpact
-58732000
CY2019Q1 orly Deferred Income Tax Expense Benefit Including Asu Adoption Adjustment Impact
DeferredIncomeTaxExpenseBenefitIncludingASUAdoptionAdjustmentImpact
4312000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5875000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5424000
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1739000
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2245000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12208000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
60914000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
106937000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
35405000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
156584000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
60918000
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
131949000
CY2019Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
82476000
CY2020Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
34613000
CY2019Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
4468000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
459093000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
440622000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
133284000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
152914000
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1901000
CY2019Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1811000
CY2020Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
95259000
CY2019Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
CY2019Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
295000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-226642000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-151398000
CY2020Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1052000000
CY2019Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
874000000
CY2020Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
969000000
CY2019Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
831000000
CY2020Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
499795000
CY2019Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2990000
CY2019Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
574052000
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
321856000
CY2020Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
9800000
CY2019Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
15224000
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-253000
CY2019Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-190000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15300000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-263822000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1090000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
246661000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
14417000
CY2020Q1 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
-5200000
CY2019Q1 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
2800000
CY2020Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
28141000
CY2019Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
32201000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1666000
CY2020Q1 orly Accounts Receivable Allowance For Credit Loss Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation
-146000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
14927000
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
83195000
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
78814000
CY2020Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1784000
CY2019Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2058000
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
20333000
CY2019Q1 us-gaap Variable Lease Cost
VariableLeaseCost
18378000
CY2020Q1 us-gaap Sublease Income
SubleaseIncome
1175000
CY2019Q1 us-gaap Sublease Income
SubleaseIncome
957000
CY2020Q1 us-gaap Lease Cost
LeaseCost
104137000
CY2019Q1 us-gaap Lease Cost
LeaseCost
98293000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
82607000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
78298000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
71131000
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10940000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2476487000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2410608000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0102
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y4M24D
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4494000000
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3911000000
CY2020Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
22752000
CY2019Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
20473000
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4471248000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3890527000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
61069000
CY2020Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
23375000
CY2020Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
22901000
CY2020Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
60595000
CY2020Q1 orly Stock Repurchase Program Increase In Authorized Amount
StockRepurchaseProgramIncreaseInAuthorizedAmount
1000000000.0
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
13800000000
CY2020Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2020Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
574037000
CY2019Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
321846000
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
927000
CY2020Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
386.71
CY2019Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
347.09
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0250
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1484000
CY2020Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1000000000.0
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.255
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.250
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
300438000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
321152000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75022000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78484000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
641000
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
813000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75663000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79297000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.00
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.09
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.97
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.05
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
349000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
176000
CY2020Q1 orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
377.41
CY2019Q1 orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
347.98

Files In Submission

Name View Source Status
0000898173-20-000027-index-headers.html Edgar Link pending
0000898173-20-000027-index.html Edgar Link pending
0000898173-20-000027.txt Edgar Link pending
0000898173-20-000027-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
orly-20200331.xsd Edgar Link pending
orly-20200331ex3116780f8.htm Edgar Link pending
orly-20200331ex3123dd2e2.htm Edgar Link pending
orly-20200331ex32103c808.htm Edgar Link pending
orly-20200331ex322ef2b5e.htm Edgar Link pending
orly-20200331x10q.htm Edgar Link pending
orly-20200331x10q_htm.xml Edgar Link completed
orly-20200331_cal.xml Edgar Link unprocessable
orly-20200331_def.xml Edgar Link unprocessable
orly-20200331_lab.xml Edgar Link unprocessable
orly-20200331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending